Daiichi Sankyo's Acquisition of Ranbaxy - Cultural Issues in Integrating Business Models and Organisations
通常価格
¥1,474 JPY
通常価格
セール価格
¥1,474 JPY
単価
あたり
Daiichi Sankyo was the first major Japanese pharmaceutical firm to acquire a generic drug company. In early 2008, it acquired a majority share in Ranbaxy, then the largest India-based generic drug manufacturer and exporter. This case examines the cross cultural challenges in the post-acquisition task of integration.
【書誌情報】
ページ数:29ページ
サイズ:A4
商品番号:HBSP-NTU298
発行日:2012/4/12
登録日:2021/4/14